Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Novel coronavirus, Laboratory testing, molecular detection, outbreak control, external quality assessment (EQA), laboratory preparedness, 【초록키워드】 coronavirus disease, coronavirus, diagnostic, Laboratory, SARS-CoV-2 testing, outbreak, molecular, questionnaire, inactivated, Support, acute respiratory syndrome, union, molecular assays, European, conducted, 【제목키워드】 COVID-19 pandemic, Laboratory, molecular,
【저자키워드】 COVID-19, SARS-CoV-2, Novel coronavirus, Laboratory testing, molecular detection, outbreak control, external quality assessment (EQA), laboratory preparedness, 【초록키워드】 coronavirus disease, coronavirus, diagnostic, Laboratory, SARS-CoV-2 testing, outbreak, molecular, questionnaire, inactivated, Support, acute respiratory syndrome, union, molecular assays, European, conducted, 【제목키워드】 COVID-19 pandemic, Laboratory, molecular,